Clinical cancer genetics has now matured to a truly multidisciplinary medical discipline in which clinical and molecular geneticists work with clinical and medical oncologists as well as with psycho-social workers.

Due to the multidisciplinary nature of clinical cancer genetics most papers are currently being published in a wide variety of journals on epidemiology, oncology and genetics. Familial Cancer provides a forum bringing these topics together, focusing on the interests and needs of the clinician.

The journal concentrates on clinical cancer genetics. Most major areas in the field are included, such as epidemiology of familial cancer, molecular analysis and diagnosis, clinical expression, treatment and prevention, counseling and the health economics of familial cancer.

Familial Cancer publishes Original Articles, Reviews, Short Communications, Book Reviews, and Letters to the Editor.

  • Encompasses all aspects of hereditary cancer of interest to the clinician, geneticist, psychosocial worker, surgical and medical oncologist
  • Coverage includes epidemiology of familial cancer, molecular analysis and diagnosis, clinical expression, treatment and prevention, counseling and the health economics of familial cancer
  • Supporting Societies and Divisions: International Society for Gastrointestinal Hereditary Tumours (InSIGHT) and The Breast Cancer Linkage Consortium (BCLC)

Journal information

Editors-in-Chief
  • Fred H. Menko,
  • Hans Vasen
Publishing model
Hybrid. Open Access options available

Journal metrics

1.760 (2019)
Impact factor
1.902 (2019)
Five year impact factor
34 days
Submission to first decision
151 days
Submission to acceptance
91,831 (2019)
Downloads

Latest articles

  1. Authors (first, second and last of 8)

    • Pål Møller
    • Julian Sampson
    • Toni Seppälä
    • Content type: Letter to the Editor

Journal updates

  • Impact of COVID-19

    As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our usual peer review process. We thank referees for their continued support in these challenging times and ask authors for their patience and understanding.

    COVID-19
View all updates

Subscribe

eJournal
$99.00
Note this is only the net price. Taxes will be calculated during checkout.
  • Immediate online access with complete access to all articles
  • Downloadable in PDF format
  • Subscription expires 12/31/2020

About this journal

Electronic ISSN
1573-7292
Print ISSN
1389-9600
Abstracted and indexed in
  1. CNKI
  2. Chemical Abstracts Service (CAS)
  3. Current Contents/Clinical Medicine
  4. EBSCO Biomedical Reference Collection
  5. EMBASE
  6. EMBiology
  7. Elsevier Biobase
  8. Japanese Science and Technology Agency (JST)
  9. Journal Citation Reports/Science Edition
  10. Medline
  11. Meta
  12. ProQuest Biological Science Database
  13. ProQuest Central
  14. ProQuest Consumer Health
  15. ProQuest Genetics Abstracts
  16. ProQuest Health & Medical Collection
  17. ProQuest Health Research Premium Collection
  18. ProQuest Medical Database
  19. ProQuest Natural Science Collection
  20. ProQuest Pharma Collection
  21. ProQuest Research Library
  22. ProQuest SciTech Premium Collection
  23. Psyndex
  24. Reaxys
  25. SCImago
  26. SCOPUS
  27. Science Citation Index Expanded (SciSearch)
  28. UGC-CARE List (India)
Copyright information

Rights and permissions

Springer policies

© Springer Nature B.V.